| Literature DB >> 24788518 |
William Lento1, Takahiro Ito, Chen Zhao, Jeffrey R Harris, Wei Huang, Chen Jiang, Kouros Owzar, Sadhna Piryani, Luigi Racioppi, Nelson Chao, Tannishtha Reya.
Abstract
Accidental or deliberate ionizing radiation exposure can be fatal due to widespread hematopoietic destruction. However, little is known about either the course of injury or the molecular pathways that regulate the subsequent regenerative response. Here we show that the Wnt signaling pathway is critically important for regeneration after radiation-induced injury. Using Wnt reporter mice, we show that radiation triggers activation of Wnt signaling in hematopoietic stem and progenitor cells. β-Catenin-deficient mice, which lack the ability to activate canonical Wnt signaling, exhibited impaired hematopoietic stem cell regeneration and bone marrow recovery after radiation. We found that, as part of the mechanism, hematopoietic stem cells lacking β-catenin fail to suppress the generation of reactive oxygen species and cannot resolve DNA double-strand breaks after radiation. Consistent with the impaired response to radiation, β-catenin-deficient mice are also unable to recover effectively after chemotherapy. Collectively, these data indicate that regenerative responses to distinct hematopoietic injuries share a genetic dependence on β-catenin and raise the possibility that modulation of Wnt signaling may be a path to improving bone marrow recovery after damage.Entities:
Keywords: Wnt signaling; hematopoietic stem cells; oxidative stress; regeneration; β-catenin
Mesh:
Substances:
Year: 2014 PMID: 24788518 PMCID: PMC4018497 DOI: 10.1101/gad.231944.113
Source DB: PubMed Journal: Genes Dev ISSN: 0890-9369 Impact factor: 11.361
Figure 1.Hematopoietic injury activates Wnt signaling in hematopoietic stem and progenitor cells. (A) Representative FACS plots and GFP reporter expression of bone marrow KLS150+48− stem cells from TCF/Lef H2B-GFP mice after 4.5 Gy. (B) Time course of reporter GFP induction in control (square) and TCF/Lef H2B-GFP (triangle) KLS150+48− cells following exposure to a single dose of 4.5 Gy (day 0, n = 11–13 per genotype; day 7, n = 7–9 per genotype; day 14, n = 6–12 per genotype; day 28, n = 5–9 per genotype). Minimal autofluorescence signal is detected in the control cells. (C) Immunofluorescence staining and quantitation of activated (nonphosphorylated) β-catenin in irradiated KLS34− cells 7 d after 4.5 Gy. (D) Representative immunofluorescence staining of Wnt10b expression in bone marrow sections from control and 4.5 Gy irradiated mouse femurs 7 d after radiation. Wnt10b is shown in red, and nuclei are stained with DAPI in blue (n = 3); control is matched IgG. (E) Expression analysis of Wnt10b protein by immunoblotting whole bone marrow from control and irradiated mice on day 7. The normalized Wnt10b levels are quantitated (N = 4–5 mice per group). (*) P < 0.05; (**) P < 0.01; (***) P < 0.001.
Figure 2.Loss of β-catenin impairs HSC function after radiation exposure. (A,B) Representative FACS plots of in vitro cultured KLS34− stem cells isolated from 4.5 Gy irradiated control and β-catenin−/− animals (n = 4 per genotype). (*) P < 0.05; (**) P < 0.005. (C) Colony formation of irradiated and sorted KLS34− cells in primary and secondary plating assays in methylcellulose medium. (**) P < 0.01 (n = 3 per genotype). (D) Whole bone marrow counts at day 28 from mice irradiated with 4.5 Gy on day 0 and day 14 (n = 11 per genotype). (**) P < 0.01. (E) Absolute number of KLS34− cells from mice in D (n = 10 per genotype). (***) P < 0.001. (F) Representative FACS plots and quantitation of in vivo BrdU labeling for cell cycle analysis on day 14 after 4.5 Gy (n = 3). (*) P < 0.05. (G) Heat map obtained from microarray analysis of gene expression in sorted KLS34− stem cells from control and β-catenin−/− animals. (H) N-acetyl-cysteine (NAC) treatment of mice irradiated with 4.5 Gy on day 0 and day 14. NAC was given by oral gavage from day 15 to 28, and the animals were sacrificed on day 35. NAC rescues bone marrow cell number, absolute KLS34− number, and KLS34− frequency.
Figure 3.Loss of β-catenin potentiates ROS generation and impairs DNA double-strand break repair. (A) Representative FACS plots of ROS and O2− in KLS cells from 4.5 Gy irradiated control and β-catenin−/− animals isolated 1 h after irradiation. (B) Quantitation of ROS and O2− double-positive KLS cells in A. (**) P < 0.005; (***) P < 0.001 compared with control cells. (C) Representative FACS histograms of ROS in irradiated KLS cells. (D) Quantitation of ROS in C. (**) P < 0.01; (***) P < 0.001. Pyocyanin served as a positive control for induction of ROS (n = 4–6 per genotype). (E,F) γ-H2A.X foci in unirradiated (E) or 4.5 Gy irradiated (F) KLS34− cells from control and β-catenin−/− animals. The inset is bounded by white lines. Approximately 20–80 cells were scored per sample (n = 6 per genotype). (*) P < 0.05. See also Supplemental Figures S4 and S5.
Figure 4.β-Catenin is required for hematopoietic regeneration following 5-FU treatment. (A) Representative H&E-stained femur sections from control and β-catenin−/− mice on day 14 after 5-FU treatment (120 mg/kg) on day 0 and day 7 (n = 3). (B) Quantitation of whole bone marrow cells in 5-FU mice treated as described in A (n = 4–9 per genotype). (**) P < 0.01. (C–F) Representative FACS plots (C) and absolute cell counts of KLS150+48− long-term stem cells (D), KLS150+48+ multipotent progenitor 1 cell populations (E), and KLS150−48+ multipotent progenitor 2 cell populations (F). The cells were pregated on live KLS cells (n = 4–9 per genotype). (*) P = 0.05. (G–J) Peripheral blood subsets from mice in C (n = 14–19 per genotype). WBCs and lymphocytes (P < 0.01); neutrophils, and platelets (P < 0.05). (K) Gene expression of Wnt target genes Axin 2 and Cyclin D1 after 5-FU injury by quantitative PCR (n = 3 per genotype). (*) P < 0.05.
Figure 5.Loss of β-catenin impairs long-term HSC self-renewal following 5-FU treatment. (A) Schematic for primary and secondary bone marrow transplants. Donor cells are CD45.2, and competitor cells are CD45.1. (B) CD45.2 donor chimerism in the peripheral blood after the transplantation of 500 5-FU-treated KLS34− cells at week 16 (left) and the bone marrow at week 18 (right) (n = 6 recipients per genotype). (*) P < 0.05. (C) Representative FACS plots of peripheral blood after secondary bone marrow transplantation (week 16). The secondary recipients received 106 whole bone marrow harvested from primary transplantation recipients sacrificed after 18 wk. (D) Secondary transplantation peripheral blood chimerism and lineage subsets at 16 wk (n = 8–10 recipients per group) and bone marrow chimerism at 20 wk (n = 7 per group). (**) P < 0.01; (***) P < 0.0005. (E) Frequency of O2−-positive KLS cells 18 h after treatment with 120 mg/kg 5-FU (n = 7 per genotype). (*) P < 0.05 (F) Kaplan-Meier plot of control and β-catenin−/− mice treated with 120 mg/kg 5-FU on days 0, 7, and 14 (n = 9–10 mice per group). P < 0.05.